Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study

Abstract Backgrounds N-acetylcysteine (NAC) has broadly been used as an anti-oxidant agent in various types of diseases. This study aimed to assess the effect of NAC on the systemic lupus erythematosus (SLE) disease activity and outcome. Methods In this randomized, double-blind clinical trial study,...

Description complète

Détails bibliographiques

Auteurs principaux:	Mitra Abbasifard, Hossein Khorramdelazad, Abdolrahman Rostamian, Mohsen Rezaian, Pooya Saeed Askari, Gholamhosein Taghipur Khajeh Sharifi, Moein Kardoust Parizi, Mobina Taghipour Khajeh Sharifi, Seyed Reza Najafizadeh
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2023-02-01
Collection:	Trials
Sujets:	Systemic lupus erythematosus N-acetylcysteine Anti-oxidant BILAG SLEDAI
Accès en ligne:	https://doi.org/10.1186/s13063-023-07083-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!